http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021155501-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d650921cf221c5360cfb1d751f240b0f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44b4085e5f05d3a42172e6e5621a0f1f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_722d3c59fdb780392fbd5a39e931362f |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate | 2020-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6facaede269eabf2f50048b52f1a80a7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb6eab58c5edae60db014909b927feef |
| publicationDate | 2021-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2021155501-A1 |
| titleOfInvention | Fusion of survivin and gm-csf, coding dna, recombinant expression vector, anti-tumor vaccine, and application thereof |
| abstract | A fusion of survivin and GM-CSF, coding DNA, a recombinant expression vector, an anti-tumor vaccine, and an application thereof. The fusion of survivin and GM-CSF includes survivin and GM-CSF that are operably linked. The DNA encoding the fusion of survivin and GM-CSF includes a survivin coding element and a GM-CSF coding element that are operably linked, wherein the survivin coding element encodes the amino acid sequence of survivin, and the GM-CSF coding element encodes the amino acid sequence of GM-CSF. The fusion effectively improves the immunogenicity of a survivin protein, and the constructed recombinant BCG vaccine achieves the effects of both a BCG vaccine vector and a therapeutic drug, and achieves the synergistic effect of an antigen, an adjuvant, and a vaccine vector, so that the immunogenicity of a tumor vaccine is more effective and lasting. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111118063-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111118063-B |
| priorityDate | 2020-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 70.